A Randomized, Double-Blind, Parallel Group Study Evaluating the Efficacy and Safety of Co-Administration of a Triple Combination Therapy of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Subjects With Hypertension.

Trial Profile

A Randomized, Double-Blind, Parallel Group Study Evaluating the Efficacy and Safety of Co-Administration of a Triple Combination Therapy of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Subjects With Hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Amlodipine; Hydrochlorothiazide; Olmesartan medoxomil/amlodipine; Olmesartan medoxomil/amlodipine/hydrochlorothiazide; Olmesartan medoxomil/hydrochlorothiazide
  • Indications Essential hypertension; Hypertension
  • Focus Registrational; Therapeutic Use
  • Acronyms TRINITY
  • Most Recent Events

    • 01 Mar 2012 Results of the open-label extension study published in the Journal of Clinical Hypertension.
    • 01 Dec 2011 Results of substudy on ambulatory blood pressure published in the Journal of Clinical Hypertension (Greenwich).
    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top